Discover how the three largest pharmacy benefit managers are rejecting biosimilars from their formularies, except for their own private-label drugs.

In its second interim staff report on pharmacy benefit managers (PBMs), released Tuesday, the FTC said CVS Health's Caremark Rx, Cigna's Express Scripts, and UnitedHealth Group's OptumRx "marked ...

Unions that provide health benefits to nearly a half-million workers — including many in Ohio — have filed nearly identical ...

“We have not seen a biosimilar manufacturer only launch through one PBM before,” Jeff Casberg, RPh, M.S., senior vice president clinical pharmacy of IPD Analytics ... biosimilar has been available on ...

Optum Rx services prescription claims for more than 66 million people across the United States, according to the lawsuit. The lawsuit alleges that the Walgreens pharmacy staffers failed to offer ...